Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

Voravit Ratanatharathorn, Lois Ayash, C. Reynolds, +5

Biology of Blood and Marrow Transplantation

Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease

Joseph P. Uberti, Lois Ayash, Voravit Ratanatharathorn, +12

Biology of Blood and Marrow Transplantation

Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Pavan Reddy, K J Johnson, Joseph P. Uberti, +5

Bone Marrow Transplantation

GlomerulonephritisGraft-versus-host DiseaseTransplantationAutoimmune DiseaseMedicine +9

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

Roy S. Herbst, Mary W. Redman, Edward S. Kim, +15

The Lancet Oncology

Advanced NsclcSwog S0819OncologyMedicineBevacizumab Versus Carboplatin +6

Trastuzumab-Induced Cardiomyopathy: Not as Benign as it Looks? A Retrospective Study

Maya Guglin, Gregory Hartlage, C. Reynolds, +2

Journal of Cardiac Failure

Retrospective StudyCardiomyopathyHeart FailureCardiovascular DiseaseTrastuzumab-induced Cardiomyopathy +3

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy

John E. Levine, Joseph P. Uberti, Lois Ayash, +7

Biology of Blood and Marrow Transplantation

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

C. Reynolds, Voravit Ratanatharathorn, Paul Adams, +9

Bone Marrow Transplantation

Cell TherapyTransplantationMarrow TransplantationDisease ProgressionStem Cell Transplantation +9

Tacrolimus as monotherapy or combined with minidose methotrexate for graft-versus-host disease prophylaxis after allogeneic peripheral blood stem cell transplantation: long-term outcomes

Joseph P. Uberti, Lois Ayash, T. Braun, +3

Bone Marrow Transplantation

Cell TherapyTransplantationMarrow TransplantationGraft-versus-host Disease ProphylaxisStem Cell Transplantation +7

An open-label, phase II trial of nanoparticle albumin bound paclitaxel (nab-paclitaxel), carboplatin, and bevacizumab in first-line patients with advanced non-squamous non-small cell lung cancer (NSCLC)

C. Reynolds, David Barrera, Dennis Vu, +7

Journal of Clinical Oncology

Cancer ManagementFirst-line PatientsPharmacotherapyPre-clinical PharmacologyNanomedicine +15

Factors Associated with Presentation of Severe Adolescent Idiopathic Scoliosis

Ian P. Erkkila, C. Reynolds, Joshua P. Weissman, +4

Journal of the Pediatric Orthopaedic Society of North America